475 completed, 95 unknown, 51 recruiting, 22 active not recruiting. 700 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 700 | Completed 475, Unknown 95, Recruiting 51, Active not recruiting 22, Not yet recruiting 19, Terminated 18, Withdrawn 10, Enrolling by invitation 9, Suspended 1 |
Follow Hyperlipidemias: new trials by email Literature Review of Hyperlipidemias trials Research Report on Hyperlipidemias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Coronary Artery Calcium (CAC) Testing in Primary Care Our Practice Advisory (OPA) - ASCVD, ASCVD Management | Not applicable | Not yet recruiting | Weill Medical College of Cornell University | 20 | 2027-02-01 | 2026-10-15 |
| Plasma Lipids-Dependent Vitamin E Metabolism During Dynamic Hyperlipidemia High fat liquid shake - Lipid Metabolism Disorders | Not applicable | Not yet recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 48 | 2026-11-18 | 2026-11-13 |
| Penn Family Screening for Familial Hypercholesterolemia (NHLBI R33) Trial 3 Cascade Screening - Familial Hypercholesterolemia | Not applicable | Not yet recruiting | Northwestern University | 110 | 2026-11-15 | 2026-11-05 |
| Cascade Testing In Identifying At-risk Family Members Of Individuals With Familial Hypercholesterolemia (FH) In PCP Cascade testing, Standard of Care - Familial Hypercholesterolemia | Not applicable | Not yet recruiting | Mayo Clinic | 480 | 2026-10-20 | 2026-09-18 |
| Metabolic Effects of an Ophiocordyceps Sinensis- and CoQ10-Based Formulation in Mild-to-Moderate Hypercholesterolemia CORDICOL, Placebo - Hypercholesterolemia, Lipid Metabolism Disorders | Not applicable | Not yet recruiting | noiVita Srls | 140 | 2026-10-19 | 2026-10-08 |
| Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors Referral to the Duke Cardiometabolic Prevention Clinic - ASCVD, Hyperlipidemia | Not applicable | Not yet recruiting | Duke University | 150 | 2026-10-02 | 2026-09-08 |
| Comparing Two Low-Carbohydrate Diets With a Standard Diet in Type 2 Diabetes High-Protein Low-Carbohydrate Diet, High-Fat Low-Carbohydrate Diet, Standard diet - Diabete Mellitus, Obesity & Overweight | Not applicable | Not yet recruiting | National Nutrition and Food Technology Institute | 168 | 2026-09-20 | 2026-09-08 |
| Berberol P for Mild-to-Moderate Hypercholesterolaemia Berberol® P (manufacturer: PharmExtracta S.p.A.), Berberol® K (manufacturer: PharmExtracta S.p.A.) - Hypercholesterolemia | Not applicable | Not yet recruiting | Liaquat University of Medical & Health Sciences | 255 | 2026-09-07 | 2026-08-27 |
| Standardized Large Yellow Tea Extract for Glucose and Lipid Metabolism in Overweight Adults With Hypertriglyceridemia Standardized Large Yellow Tea Extract, Placebo - Hypertriglyceridemia, Overweight , Obesity | Not applicable | Not yet recruiting | The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial) | 138 | 2026-09-01 | 2026-09-25 |
| Electronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial LDL-C information letter, Lp(a) information letter - Ischemic Heart Disease, Coronary Artery Disease | Not applicable | Not yet recruiting | Tor Biering-Sørensen | 123000 | 2026-09-01 | 2026-09-08 |
| Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study Pharmacist-led lipid optimization pathway - ACS (Acute Coronary Syndrome), Hyperlipidemia | Not applicable | Recruiting | University of Alberta | 2000 | 2026-08-10 | 2026-09-09 |
| Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD Moderate-intensity statin and ezetimibe combination therapy, High-intensity statin monotherapy - Renal Insufficiency, Atherosclerosis | Not applicable | Recruiting | Yonsei University | 1952 | 2026-05-28 | 2026-06-16 |
| Pemafibrate for Symptomatic ICAS RCT Pemafibrate - Intracranial Atherosclerotic Disease (ICAD), Hypertriglyceridaemia | Not applicable | Recruiting | Tokyo Women's Medical University | 270 | 2026-05-26 | 2026-11-09 |
| Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors PC2: Primary Care Connect - Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Not applicable | Enrolling by invitation | Rutgers, The State University of New Jersey | 266 | 2026-04-24 | 2026-07-10 |
| Clinical Trial On The Effect Of Artisterol On Risk Factors In Individuals With Suboptimal Cholesterol Levels investigational product containing phytosterol, artichoke extract and thiamin, Placebo - Hyperlipoproteinemia | Not applicable | Recruiting | Zentiva, k.s. | 106 | 2026-04-24 | 2026-05-12 |
| Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile corn oil, Avocado Oil - Hypercholesterolemia | Not applicable | Recruiting | Midwest Center for Metabolic and Cardiovascular Research | 54 | 2026-04-10 | 2026-04-17 |
| Virtual Lifestyle Intervention for Weight Management and Cardiovascular Heal Multicomponent Virtual Lifestyle Intervention - Cardiovascular Risk Factor | Not applicable | Enrolling by invitation | Truemedicine Inc | 200 | 2026-04-10 | 2026-05-07 |
| WB-EMS Effects on Cardiometabolic Risk Factors WB-EMS, Control - Hypertension, Metabolic Syndrome | Not applicable | Active not recruiting | University of Erlangen-Nürnberg Medical School | 28 | 2026-02-15 | 2026-05-14 |
| The ORIGIN-FH Study Screening for FH - Heterozygous Familial Hypercholesterolemia (HeFH), Homozygous Familial Hypercholesterolemia (HoFH) | Not applicable | Recruiting | University of Wisconsin, Madison | 70 | 2026-02-14 | 2026-10-13 |
| New Taipei City 888 Digital Medical AI Platform for Prevention and Care of the Three Highs and Cardio-Renal-Vascular Diseases Interactive digital modules, Antihypertensive Medication Management - Microalbuminuria, Microalbuminuria /Creatinine Ratios ACR | Not applicable | Recruiting | New Taipei City Medical Association | 4162 | 2026-02-05 | 2026-05-14 |
Showing 20 of 700. Sign in to see all of them.
Hypercholesterolemia (309) · Hypertension (186) · Diabetes Mellitus (123) · Obesity (116) · Cardiovascular Diseases (92) · Hypertriglyceridemia (89) · Diabetes Mellitus, Type 2 (51) · Metabolic Syndrome (48) · Overweight (48) · Hyperlipoproteinemia Type II (47) · Dyslipidemias (40) · Motor Activity (33) · Hyperglycemia (32) · Inflammation (27)
Nutritional and Metabolic Diseases (697) · Lipid Metabolism Disorders (692) · Metabolic Diseases (691) · Dyslipidemias (660) · Glucose Metabolism Disorders (228) · Vascular Diseases (228) · Cardiovascular Diseases (197) · Pathological Conditions, Signs and Symptoms (195) · Endocrine System Diseases (173) · Signs and Symptoms (152) · Body Weight (138) · Nutrition Disorders (136) · Overnutrition (134) · Behavior (90)
Diet (15) · Exercise (15) · Phytosterols (15) · Simvastatin (11) · Atorvastatin (10) · Diet Therapy (9) · Ezetimibe (7) · Fish Oils (7) · Rosuvastatin Calcium (7) · plant stanol ester (7) · Control Groups (6) · Docosahexaenoic Acids (6) · Nutrition Assessment (6) · Standard of Care (6) · Glucose (5)
University of Bologna (10) · Raisio Group (9) · University of Pennsylvania (9) · Brigham and Women's Hospital (7) · Maastricht University Medical Center (7) · Mayo Clinic (7) · University of Manitoba (7) · Northwestern University (6) · VA Office of Research and Development (6) · Washington University School of Medicine (6) · HealthPartners Institute (5) · Montana State University (5) · Stanford University (5) · University Health Network, Toronto (5) · University of Jena (5)
United States (261) · Canada (49) · China (28) · Italy (27) · France (22) · Germany (21) · Spain (21) · United Kingdom (19) · Netherlands (15) · Taiwan (15) · Pakistan (14) · South Korea (12) · Denmark (11) · Australia (9) · Norway (8)
Christopher D Gardner (4) · Claudio Borghi, MD (4) · Gerhard Jahreis, Prof. Dr. (4) · Peter Jones, PhD (4) · Benoit Lamarche, PhD (3) · Fernando Civeira, MD, PhD (3) · Hayden B Bosworth, PhD (3) · Jiri Frohlich, MD (3) · Mary P Miles, PhD (3) · Alexander Fanaroff, MD, MHS (2) · Alice H Lichtenstein, D.Sc. (2) · Aline Marcadenti, PhD (2) · Benjamin Druss, MD, MPH (2) · Carla Taylor, PhD (2) · Darshan S Kelley, PhD (2)
PMID 25456098, PMID 28487349, PMID 33380172, PMID 12485966, PMID 12620529, PMID 14519406, PMID 14552849, PMID 14679383, PMID 14728353, PMID 14728575, PMID 15247520, PMID 15464042, PMID 15534158, PMID 15791767, PMID 15802479, PMID 16373244, PMID 16522904, PMID 16530201, PMID 16818923, PMID 16843192, PMID 16919541, PMID 16940448, PMID 17101639, PMID 17384344, PMID 17520105, PMID 17521443, PMID 17684201, PMID 17957346, PMID 17998497, PMID 18038131, PMID 18078870, PMID 18156400, PMID 18327998, PMID 18439712, PMID 18541599, PMID 18559131, PMID 18650989, PMID 18754003, PMID 18957532, PMID 18996523, PMID 19081418, PMID 19195513, PMID 19200384, PMID 19369238, PMID 19423109, PMID 19463517, PMID 19528562, PMID 19709787, PMID 19786378, PMID 19889819
2018 (3), 2023 (3), OT2HL158287 (3), 2025 (2), P01HS021141 (2), 7RC4AG039072-02 (1), I01HX003477 (1), K23AR068449 (1), K23HL090505 (1), K24DK068380 (1), M01RR000042 (1), M01RR000400 (1), P01AG018784 (1), P30AG022849 (1), P50MD017342 (1)